Skip to main content

MoneyWorks4Me

Biocon informs about press release

09 Feb 2024 Evaluate
Biocon has informed that it enclosed the press release titled ‘Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab.’ The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.95
Dr. Reddys Labs. 1380.00
Cipla 1394.00
Lupin 1972.50
Zydus Lifesciences 1189.00
View more..